rare egfr mutations in lung adenocarcinoma
Published 5 years ago • 69 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
3:30
osimertinib for uncommon egfr mutations in nsclc
-
1:41
egfr mutations in patients with lung cancer
-
2:11
identifying rare mutations in lung cancer
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations
-
1:13
identification of egfr mutations impact overall prognosis in lung cancers
-
1:21
detectability of uncommon egfr mutations in nsclc: ngs versus pcr
-
2:21
what is an egfr mutation in lung cancer?
-
4:10
egfr mutations in advanced nsclc - targeted therapies in lung cancer 2023
-
4:06
afatinib in patients with uncommon egfr mutations
-
3:34
repeat biopsy in lung cancer patients with egfr mutation
-
2:26
egfr mutations in nsclc
-
1:04
ngs provides improved identification of uncommon egfr mutations over pcr in nsclc
-
6:57
egfr exon 20 mutations in non–small cell lung cancer
-
0:37
response to systemic anti-cancer therapy in uncommon egfr mutations
-
3:41
how do doctors treat lung cancer with egfr mutations?
-
3:31
osimertinib plus gefitinib for treatment of egfr-mutated non-small cell lung cancer
-
1:47
dr. west on fda approval of afatinib in nsclc with rare egfr mutations
-
15:35
asco 2020: latest developments in egfr-mutated non-small cell lung cancer
-
2:23
therapeutic strategies for egfr-mutated lung cancer